Federal contract award

W911SR24F0016

PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeW6QK ACC-APG
NAICS325411 — Medicinal and Botanical Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleW911SR24D0001
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$41.8M
Current contract value$41.8M
Potential contract value / ceiling$41.8M
Start dateJan 22, 2024
Current end dateNov 30, 2025
Potential end dateNov 30, 2025
Latest award activitySep 17, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 17, 2025P00006$0THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE DELIVERY DATE OF CLIN 1001 FROM 25 SEPTEMBER 2025 TO 30 NOVEMBER 2025.
Mar 13, 2025P00005$6.9MTHE PURPOSE OF THIS MODIFICATION IS TO PROCURE BIOTHRAX (ANTHRAX VACCINE ADSORBED).
Jan 22, 2025P00004$6.9MTHE PURPOSE OF THIS MODIFICATION IS TO PROCURE BIOTHRAX (ANTHRAX VACCINE ADSORBED).
Dec 11, 2024P00003$6.9MTHE PURPOSE OF THIS DELIVERY ORDER IS FOR THE PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED).
Mar 21, 2024P00002$7.8MPROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED).
Feb 13, 2024P00001$6.7MPROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)
Jan 19, 20240$6.5MPROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.